|
|
Volumn 24, Issue 8, 2001, Pages 935-940
|
|
Molecular and pharmacokinetic properties of 222 commercially available oral drugs in humans
|
|
Author keywords
Exclusion criteria; Lipophilicity; Molecular weight; Oral absorption
|
|
Indexed keywords
AMIODARONE;
AURANOFIN;
AZITHROMYCIN;
BROMOCRIPTINE;
CALCIUM CHANNEL BLOCKING AGENT;
CEFPODOXIME;
CEPHALOSPORIN;
CHLOROQUINE;
CHLORPROMAZINE;
CLARITHROMYCIN;
CYCLOSPORIN A;
DEXAMETHASONE;
DIGITOXIN;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ERYTHROMYCIN;
ETOPOSIDE;
FOSINOPRIL;
GANCICLOVIR;
GLYCOPROTEIN P;
ITRACONAZOLE;
LIDOCAINE;
MEVINOLIN;
NADOLOL;
PROPRANOLOL;
QUINIDINE;
RIFABUTIN;
TACROLIMUS;
TIMOLOL;
UNINDEXED DRUG;
ARTICLE;
CHEMICAL MODIFICATION;
COMMERCIAL PHENOMENA;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG DEVELOPMENT;
DRUG EXCRETION;
DRUG INTERACTION;
DRUG STRUCTURE;
HYDROGEN BOND;
MELTING POINT;
MOLECULAR DYNAMICS;
MOLECULAR WEIGHT;
MONEY;
PHARMACOKINETICS;
STRUCTURE ACTIVITY RELATION;
TIME;
URINARY EXCRETION;
ADMINISTRATION, ORAL;
ANTI-INFECTIVE AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CHEMISTRY, PHYSICAL;
HUMANS;
MOLECULAR WEIGHT;
PHARMACEUTICAL PREPARATIONS;
PHARMACOKINETICS;
|
|
EID: 0034872131
PISSN: 09186158
EISSN: None
Source Type: Journal
DOI: 10.1248/bpb.24.935 Document Type: Article |
|
Times cited : (60)
|
|
References (27)
|
